DEA Approves First Ever Marijuana Study for Veterans with PTSD
Avr29

DEA Approves First Ever Marijuana Study for Veterans with PTSD

The United States Drug Enforcement Administration (DEA) has given formal approval to a controlled clinical trial to study the effectiveness of whole-plant cannabis as a treatment for post-traumatic stress disorder (PTSD) in military veterans, the California-based non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) announced last week. Post-traumatic stress disorder is an anxiety disorder that impacts an estimated...

Lire plus
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
Avr02

Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?

OBJECTIVES: This study examines the concept of clinical endocannabinoid deficiency (CECD), and the prospect that it could underlie the pathophysiology of migraine, fibromyalgia, irritable bowel syndrome, and other functional conditions alleviated by clinical cannabis. METHODS: Available literature was reviewed, and literature searches pursued via the National Library of Medicine database and other resources. RESULTS: Migraine has...

Lire plus
Cannabis and schizophrenia
Fév08

Cannabis and schizophrenia

Cannabis and schizophrenia John Rathbone1, Hannele Variend2, and Hetal Mehta31HEDS, ScHARR, The University of Sheffield, Sheffield, UK 2CRHT, Becklin Centre, Leeds, UK 3Lancashire Care NHS Trust, Guild Lodge, Preston, UK Abstract Background—Many people with schizophrenia use cannabis and its effects on the illness are unclear. Objectives—To evaluate the effects of cannabis use on people with schizophrenia and schizophrenia-like...

Lire plus
Étude – Ados : fumer du cannabis ne rendrait pas moins intelligent
Jan23

Étude – Ados : fumer du cannabis ne rendrait pas moins intelligent

La consommation de cannabis chez les ados entraînerait un déclin du quotient intellectuel. Mais une étude sur les jumeaux suggère que le lien n’est pas aussi clair.  Si vous avez grandi dans les années 80 ou 90, vous avez sûrement dû tomber sur des clips télé délivrant le message suivant : le cannabis rend bête. Au Etats-Unis, les candidats républicains, comme Donald Trump, font même de la lutte contre la consommation de...

Lire plus
CB2 Receptors Help Treat Alzheimers, Dementia and M.S, New Study Finds
Août12

CB2 Receptors Help Treat Alzheimers, Dementia and M.S, New Study Finds

CB2 Receptors Help Treat Alzheimers, Dementia and M.S Traditional endocannabinoid biochemistry holds that there are two main endocannabinoid receptors while others exist as candidates. The two most studied cannabinoid receptors in the human body are the CB1 and CB2 receptors. Customarily, we are taught that CB1 receptors are located within the central nervous system (CNS) and CB2 are expressed outside the CNS in peripheral systems...

Lire plus
Study: Cannabidiol (CBD) as an Effective Asthma Treatment
Août03

Study: Cannabidiol (CBD) as an Effective Asthma Treatment

Atopic diseases, or those that cause an individual to experience immediate allergic reactions (asthma being one of the more common), affect about 20 percent of the population in developed countries.Researchers looking for a way to combat the longtime public health concern conducted a series of testsinvolving the use of cannabidiol (CBD).  Although the research used rats as subjects the results are nonetheless encouraging. Early...

Lire plus